ALK aims to contribute to overcoming barriers to access by continuing efforts in driving solid, evidence-based research and development of state-of-the art pharmaceutical products, including maintaining their applicability across genders, ages and ethnicity.
ALK plays a vital role in strengthening healthcare systems to ensure safe, effective and quality medicines for people with allergy.
Through our expertise and capacity, we help strengthen local health systems through training and educational activities for health care professionals (HCP) in alignment with local needs, either ourselves or through appropriate partners to mitigate any potential conflicts of interest.
New business models and partnerships with healthcare systems and HCPs are explored to enable accessibility in areas and geographies, both developed and emerging, to an increasing number of countries and patients across the globe.
ALK’s responsibility also extends to awareness raising activities, training and education efforts of both HCPs and people challenged by allergy.